Oscar Health Inc. (NYSE: OSCR) reported Q2 EPS of ($0.07), $0.15 better than the analyst estimate of ($0.22). Revenue for the quarter came in at $1.52 billion versus the consensus estimate of $1.38 billion.

For earnings history and earnings-related data on Oscar Health Inc. (OSCR) click here.